Crossmark

Loading dose and 12-month outcomes in treatment-naïve patients with neovascular age-related macular degeneration treated with faricimab, with AI-based analysis of fluid dynamics

Crossref DOI link: https://doi.org/10.1007/s10792-026-04003-z

Published Online: 2026-02-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Barbosa, Mickael

Bartolomeo, Nicolò

Schuetz, Yannic Pannatier

Nascimbeni, Anna C.

Castro, Daniela Gallo

Barry, Mamadou Pathé

Ambresin, Aude
License Information

Text and Data Mining valid from 2026-02-19

Version of Record valid from 2026-02-19
More Information

Article History

Received: 12 August 2025

Accepted: 10 February 2026

First Online: 19 February 2026

Declarations

:

: The other authors declare no proprietary or commercial interests with regard to any of the content discussed in this article.

Document is current

Any future updates will be listed below